Aldoxorubicin
Aldoxorubicin
Aldoxorubicin (pronunciation: al-dox-oh-roo-bi-sin) is a chemotherapy drug used in the treatment of various types of cancer, including sarcoma, leukemia, and lymphoma. It is a derivative of doxorubicin, a commonly used chemotherapy drug, and is designed to deliver the drug more effectively to cancer cells while reducing the side effects associated with doxorubicin.
Etymology
The name "Aldoxorubicin" is derived from the parent drug "doxorubicin", with the prefix "Al-" referring to the aldehyde group that is added to the doxorubicin molecule to create the new drug.
Mechanism of Action
Aldoxorubicin works by binding to the DNA in cancer cells and preventing them from dividing and growing. The aldehyde group allows the drug to bind more specifically to cancer cells, reducing the impact on healthy cells and potentially reducing side effects.
Related Terms
- Chemotherapy: A type of cancer treatment that uses drugs to kill cancer cells.
- Doxorubicin: A chemotherapy drug that is used to treat many types of cancer. Aldoxorubicin is a derivative of doxorubicin.
- DNA: The genetic material in cells that carries instructions for the growth, development, functioning, and reproduction of all known organisms and many viruses.
- Sarcoma: A type of cancer that begins in the bones and soft tissues.
- Leukemia: A type of cancer that starts in blood-forming tissue, such as the bone marrow, and causes large numbers of abnormal blood cells to be produced and enter the bloodstream.
- Lymphoma: A type of cancer that begins in the cells of the immune system.
External links
- Medical encyclopedia article on Aldoxorubicin
- Wikipedia's article - Aldoxorubicin
This WikiMD article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski